• Follow
  • Follow
  • Menu Item

Log in

Subscribe Today
G2 Intelligence
  • Industry Perspectives
  • Industry News
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Subscriber Articles
    • Editor Exclusives
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LAB INDUSTRY REPORT

NATIONAL LAB REPORTER

Three Common PGx Compliance Traps for Laboratories to Avoid

Three Common PGx Compliance Traps for Laboratories to Avoid

by Glenn S. Demby | Aug 5, 2021 | Blog, Open Content

By Adam M. Walters Walters Law, P.C. In recent years, many clinical laboratories have started offering Pharmacogenetics Testing (PGx) to assist physicians in avoiding prescribing medication doses that may cause adverse reactions in patients with certain genotypes...
CDC Updates Guidelines on Laboratory Testing for Sexually Transmitted Infections

CDC Updates Guidelines on Laboratory Testing for Sexually Transmitted Infections

by Glenn S. Demby | Aug 2, 2021 | Articles, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

...

This content is for Paid Members only.
Login Join Now
New Evidence Supports Suitability of Antigen Testing for COVID-19 Screening

New Evidence Supports Suitability of Antigen Testing for COVID-19 Screening

by Glenn S. Demby | Aug 2, 2021 | Articles, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Testing Trends-dtet

...

This content is for Paid Members only.
Login Join Now
New Evidence Supports Suitability of Antigen Testing for COVID-19 Screening

New Evidence Supports Suitability of Antigen Testing for COVID-19 Screening

by Glenn S. Demby | Jul 29, 2021 | Articles, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Testing Trends-dtet

...

This content is for Paid Members only.
Login Join Now

CDC/NIH Team with Local Health Authorities to Promote, Evaluate Home COVID-19 Testing

by Glenn S. Demby | May 10, 2021 | Articles, Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

...

This content is for Paid Members only.
Login Join Now
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Privacy Policy
  • Terms
  • About Us
    • G2 Intelligence Team
    • Contact Us
  • Homepage
  • FAQ
Copyright © 2022 G2 Intelligence.com